SynthesisBritish journal of cancer2009

Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness.

J S Thompson Coon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.